{"DataElement":{"publicId":"7784742","version":"1","preferredName":"Child Planned Treatment Regimen Study Protocol Identifier","preferredDefinition":"Identifier used to uniquely identify the study protocol that will be used for a child's planned treatment regimen.","longName":"CH_PLND_TX_RGM_SDY_PRT_IDF","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"7784739","version":"1","preferredName":"Child Planned Treatment Regimen","preferredDefinition":"An age group comprised of individuals who are not yet an adult. The specific cut-off age will vary by purpose._The intended treatment plan that specifies the dosage, the schedule, and the duration of treatment.","longName":"2793416v1.0:7784737v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2793416","version":"1","preferredName":"Child","preferredDefinition":"A son or daughter of any age, including biological offspring and sometimes including unborn children, adopted children, stepchildren, foster children and children born outside of marriage; person under an age specified by law.","longName":"C16423","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Child","conceptCode":"C16423","definition":"An age group comprised of individuals who are not yet an adult. The specific cut-off age will vary by purpose.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"58C3A8B5-AA53-6C47-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-08","endDate":null,"createdBy":"PANH","dateCreated":"2008-10-08","modifiedBy":"ONEDATA","dateModified":"2008-10-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7784737","version":"1","preferredName":"Planned Treatment Regimen","preferredDefinition":"The intended treatment plan that specifies the dosage, the schedule, and the duration of treatment.","longName":"C103161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Planned Treatment Regimen","conceptCode":"C103161","definition":"The intended treatment plan that specifies the dosage, the schedule, and the duration of treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC28E5D9-1FE0-2706-E053-4EBD850A1A2C","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-16","modifiedBy":"ONEDATA","dateModified":"2021-09-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC28E5D9-1FF1-2706-E053-4EBD850A1A2C","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-16","modifiedBy":"MAESKEB","dateModified":"2021-09-24","changeDescription":"Created for protocol ACCL20N1CD","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7784741","version":"1","preferredName":"Study Protocol Identifier","preferredDefinition":"The characters assigned to identify a study protocol.","longName":"7784741v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"DFCI 16-001","valueDescription":"DFCI 16-001","ValueMeaning":{"publicId":"7784745","version":"1","preferredName":"DFCI 16-001","longName":"7784745","preferredDefinition":"DFCI 16-001, Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC28309A-9E9F-2607-E053-4EBD850A75B8","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-17","modifiedBy":"ONEDATA","dateModified":"2021-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CC28309A-9EB8-2607-E053-4EBD850A75B8","beginDate":"2021-09-17","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-17","modifiedBy":"ONEDATA","dateModified":"2021-09-17","deletedIndicator":"No"},{"value":"St. Jude Total Therapy XVII (TOT17)","valueDescription":"St. Jude Total Therapy XVII (TOT17)","ValueMeaning":{"publicId":"7784743","version":"1","preferredName":"St. Jude Total Therapy XVII (TOT17)","longName":"7784743","preferredDefinition":"St. Jude Children's Research Hospital, Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC28309A-9E59-2607-E053-4EBD850A75B8","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-17","modifiedBy":"ONEDATA","dateModified":"2021-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CC28309A-9E72-2607-E053-4EBD850A75B8","beginDate":"2021-09-17","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-17","modifiedBy":"ONEDATA","dateModified":"2021-09-17","deletedIndicator":"No"},{"value":"DFCI 22-001","valueDescription":"DFCI 22-001","ValueMeaning":{"publicId":"7784744","version":"1","preferredName":"DFCI 22-001","longName":"7784744","preferredDefinition":"Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia (ALL) Consortium Protocol 22-001","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC28309A-9E7C-2607-E053-4EBD850A75B8","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-17","modifiedBy":"ONEDATA","dateModified":"2021-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CC28309A-9E95-2607-E053-4EBD850A75B8","beginDate":"2021-09-17","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-17","modifiedBy":"ONEDATA","dateModified":"2021-09-17","deletedIndicator":"No"},{"value":"DFCI 11-001","valueDescription":"DFCI 11-001","ValueMeaning":{"publicId":"7784746","version":"1","preferredName":"DFCI 11-001","longName":"7784746","preferredDefinition":"DFCI 11-001, Randomized Study of Pegasparagase (SS-PEG) and Calaspargase Pegol (SC-PEG) in Pediatric Patients with Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC28309A-9EC2-2607-E053-4EBD850A75B8","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-17","modifiedBy":"ONEDATA","dateModified":"2021-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CC28309A-9EDB-2607-E053-4EBD850A75B8","beginDate":"2021-09-16","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-17","modifiedBy":"ONEDATA","dateModified":"2021-09-17","deletedIndicator":"No"},{"value":"COG AALL1732","valueDescription":"COG AALL1732","ValueMeaning":{"publicId":"7784747","version":"1","preferredName":"COG AALL1732","longName":"7784747","preferredDefinition":"COG AALL1732, A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494, NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC28309A-9EE5-2607-E053-4EBD850A75B8","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-17","modifiedBy":"ONEDATA","dateModified":"2021-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CC28309A-9EFE-2607-E053-4EBD850A75B8","beginDate":"2021-09-16","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-17","modifiedBy":"ONEDATA","dateModified":"2021-09-17","deletedIndicator":"No"},{"value":"COG AALL1731","valueDescription":"COG AALL1731","ValueMeaning":{"publicId":"7784748","version":"1","preferredName":"COG AALL1731","longName":"7784748","preferredDefinition":"COG AALL1731, A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma (B-LLy)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC28309A-9F08-2607-E053-4EBD850A75B8","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-17","modifiedBy":"ONEDATA","dateModified":"2021-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CC28309A-9F21-2607-E053-4EBD850A75B8","beginDate":"2021-09-16","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-17","modifiedBy":"ONEDATA","dateModified":"2021-09-17","deletedIndicator":"No"},{"value":"COG AALL1131","valueDescription":"COG AALL1131","ValueMeaning":{"publicId":"7784749","version":"1","preferredName":"COG AALL1131","longName":"7784749","preferredDefinition":"COG AALL1131, A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (IND#73789, NSC#732517) in Patients with Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC28309A-9F2B-2607-E053-4EBD850A75B8","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-17","modifiedBy":"ONEDATA","dateModified":"2021-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CC28309A-9F44-2607-E053-4EBD850A75B8","beginDate":"2021-09-16","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-17","modifiedBy":"ONEDATA","dateModified":"2021-09-17","deletedIndicator":"No"},{"value":"COG AALL0932","valueDescription":"COG AALL0932","ValueMeaning":{"publicId":"7784750","version":"1","preferredName":"COG AALL0932","longName":"7784750","preferredDefinition":"COG AALL0932, Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC28309A-9F4E-2607-E053-4EBD850A75B8","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-17","modifiedBy":"ONEDATA","dateModified":"2021-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CC28309A-9F67-2607-E053-4EBD850A75B8","beginDate":"2021-09-16","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-17","modifiedBy":"ONEDATA","dateModified":"2021-09-17","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"6424136","version":"1","preferredName":"Other","longName":"6424136","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"753441A1-068C-5A23-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 Alt VM added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CC28309A-9F71-2607-E053-4EBD850A75B8","beginDate":"2021-09-17","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-17","modifiedBy":"ONEDATA","dateModified":"2021-09-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008529","version":"1","preferredName":"Research Protocols","preferredDefinition":"the identification of cancer research protocols.","longName":"RSCH_PROT","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECC2BE-2F27-348A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7784740","version":"1","preferredName":"Study Protocol Identifier","preferredDefinition":"The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","longName":"C70817:C25364","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Study Protocol","conceptCode":"C70817","definition":"The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Identifier","conceptCode":"C25364","definition":"One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC299A09-F789-1D95-E053-4EBD850AA532","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-16","modifiedBy":"ONEDATA","dateModified":"2021-09-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC299A09-F79A-1D95-E053-4EBD850AA532","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-16","modifiedBy":"MAESKEB","dateModified":"2021-09-24","changeDescription":"Created for protocol ACCL20N1CD","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"What is the index child's pla","type":"Preferred Question Text","description":"What is the index child's planned treatment regimen?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC29A50D-2383-2739-E053-4EBD850AEA56","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"PONCEO","dateCreated":"2021-09-16","modifiedBy":"PONCEO","dateModified":"2021-09-24","changeDescription":"Created for protocol ACCL20N1CD","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}